Understanding the Feasibility and Benefits of Exercise Programs in Individuals Living With a Brain Cancer Diagnosis: A Scoping Review Protocol
DOI:
https://doi.org/10.15273/hpj.v4i3.11984Palavras-chave:
cancer, physical activity, review protocol, brain cancer, GBMResumo
Objective: To describe a scoping review that aims to summarize the evidence of exercise interventions in individuals living with a primary brain cancer diagnosis. This work will map the implementation and characteristics of targeted exercise interventions designed to lower symptom burden and improve overall quality of life for those living with and beyond primary brain cancer. Introduction: Individuals with primary brain cancer are often challenged by several highly debilitating physical, cognitive, and emotional side effects that can negatively impact overall quality of life. Exercise has the potential to aid in decreasing the burden of these symptoms; however, the use of exercise as a therapeutic intervention for individuals living with brain cancer has been limited and much is left to be explored. Inclusion criteria: Studies considered for this review will explore exercise-based interventions in individuals diagnosed with primary brain cancer. Methods: This scoping review will be conducted in accordance with Joanna Briggs Institute (JBI) methodology. Databases will be searched from inception to present and will include CINAHL, MEDLINE, Embase, SPORTDiscus, Scopus, and PsycInfo. A comprehensive search strategy was developed in accordance with JBI methodology to retrieve relevant sources. Two independent reviewers will screen titles, abstracts, and full texts of relevant sources. The results of the search and the study inclusion process will be reported in full in a PRISMA-ScR flow diagram. Data will be extracted by two independent reviewers and then mapped under the FITT (frequency, intensity, time, type) principles. The results will be presented narratively, using appropriate tables and figures. Conclusion: This review will provide a comprehensive summary of the feasibility and efficacy/effectiveness of exercise interventions for individuals living with primary brain cancer. This work will also describe the exercise protocols of the reviewed interventions and will highlight strategies to improve intervention design and implementation.
Referências
Armstrong, T. S., Vera-Bolanos, E., Acquaye, A. A., Gilbert, M. R., Ladha, H., & Mendoza, T. (2016). The symptom burden of primary brain tumors: Evidence for a core set of tumor- and treatment-related symptoms. Neuro-Oncology, 18(2), 252–260. https://doi.org/10.1093/neuonc/nov166
Arvold, N. D., Armstrong, T. S., Warren, K. E., Chang, S. M., DeAngelis, L. M., Blakeley, J., Chamberlain, M. C., Dunbar, E., Loong, H. H., Macdonald, D. R., Reardon, D. A., Vogelbaum, M. A., Yuan, Y., Weller, M., van den Bent, M., & Wen, P. Y. (2018). Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group. Neuro-Oncology, 20(7), 897–906. https://doi.org/10.1093/neuonc/noy056
Barnholtz-Sloan, J. S., Ostrom, Q. T., & Cote, D. (2018). Epidemiology of brain tumors. Neurologic Clinics, 36(3), 395–419. https://doi.org/10.1016/j.ncl.2018.04.001
Canadian Agency for Drugs and Technologies in Health. (2019, April). Grey matters: A practical tool for searching health-related grey literature. https://www.cda-amc.ca/sites/default/files/is/Grey%20Matters_EN-2019.doc
Dietrich, J., Rao, K., Pastorino, S., & Kesari, S. (2011). Corticosteroids in brain cancer patients: Benefits and pitfalls. Expert Review of Clinical Pharmacology, 4(2), 233–242. https://doi.org/10.1586/ecp.11.1
Ensign, S. F., & Porter, A. B. (2022). Chapter 33: Neurological complications of steroids and of supportive care. In H. B. Newton & M. G. Malkin (Eds.), Neurological complications of systemic cancer and antineoplastic therapy (2nd ed., pp. 553–561). Elsevier. https://doi.org/10.1016/B978-0-12-821976-8.00010-4
Frikkel, J., Beckmann, M., De Lazzari, N., Götte, M., Kasper, S., Hense, J., Schuler, M., Teufel, M., & Tewes, M. (2021). Changes in fatigue, barriers, and predictors towards physical activity in advanced cancer patients over a period of 12 months—A comparative study. Supportive Care in Cancer, 29(9), 5127–5137. https://dx.doi.org/10.1007/s00520-021-06020-3
Galvão, D. A., Taaffe, D. R., Spry, N., Joseph, D., & Newton, R. U. (2010). Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: A randomized controlled trial. Journal of Clinical Oncology, 28(2), 340–347. https://doi.org/10.1200/JCO.2009.23.2488
Hanif, F., Muzaffar, K., Perveen, K., Malhi, S. M., & Simjee, S. U. (2017). Glioblastoma multiforme: A review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pacific Journal of Cancer Prevention, 18(1), 3–9. https://doi.org/10.22034/APJCP.2017.18.1.3
Hurley, D. A., Murphy, L. C., Hayes, D., Hall, A. M., Toomey, E., McDonough, S. M., Lonsdale, C., Walsh, N. E., Guerin, S., & Matthews, J. (2015). Using intervention mapping to develop a theory-driven, group-based complex intervention to support self-management of osteoarthritis and low back pain (SOLAS). Implementation Science, 11, Article 56. https://doi.org/10.1186/s13012-016-0418-2
Khaleqi-Sohi, M., Sadria, G., Ghalibafian, M., Khademi-Kalantari, K., & Irannejad, S. (2022). The effects of physical activity and exercise therapy on pediatric brain tumor survivors: A systematic review. Journal of Bodywork and Movement Therapies, 30, 1–9. https://doi.org/10.1016/j.jbmt.2021.11.003
Kim, K. N., LaRiviere, M., Macduffie, E., White, C. A., Jordan-Luft, M. M., Anderson, E., Ziegler, M., Radcliff, J. A., & Jones, J. (2023). Use of glucocorticoids in patients with cancer: Potential benefits, harms, and practical considerations for clinical practice. Practical Radiation Oncology, 13(1), 28–40. https://doi.org/10.1016/j.prro.2022.07.003
Liang, J., Lv, X., Lu, C., Ye, X., Chen, X., Fu, J., Luo, C., & Zhao, Y. (2020). Prognostic factors of patients with gliomas—An analysis on 335 patients with glioblastoma and other forms of gliomas. BMC Cancer, 20, Article 35. https://doi.org/10.1186/s12885-019-6511-6
Mao, Y., Desmeules, M., Semenciw, R. M., Hill, G., Gaudette, L., & Wigle, D. T. (1991). Increasing brain cancer rates in Canada. Canadian Medical Association Journal, 145(12), 1583–1591.
McNeely, M. L., Sellar, C., Williamson, T., Shea-Budgell, M., Joy, A. A., Lau, H. Y., Easaw, J. C., Murtha, A. D., Vallance, J., Courneya, K., Mackey, J. R., Parliament, M., & Culos-Reed, N. (2019). Community-based exercise for health promotion and secondary cancer prevention in Canada: Protocol for a hybrid effectiveness-implementation study. BMJ Open, 9(9), Article e029975. https://doi.org/10.1136/bmjopen-2019-029975
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372(8284), Article n71. https://doi.org/10.1136/bmj.n71
PDQ Adult Treatment Editorial Board (2022). Adult central nervous system tumors treatment (PDQ®)—Health professional version. National Cancer Institute. Retrieved January 31, 2024, from https://www.cancer.gov/types/brain/hp/adult-brain-treatment-pdq
Peters, M. D. J., Godfrey, C., McInerney, P., Munn, Z., Tricco, A. C., & Khalil, H. (2020). Chapter 11: Scoping reviews. In E. Aromataris & Z. Munn (Eds.), JBI reviewer’s manual. https://doi.org/10.46658/JBIRM-20-01
Rethorst, C. D., Hamann, H. A., Carmody, T. J., Sharp, K. J., Argenbright, K. E., Haley, B. B., Skinner, C. S., & Trivedi, M. H. (2018). The Promoting Activity in Cancer Survivors (PACES) trial: A multiphase optimization of strategy approach to increasing physical activity in breast cancer survivors. BMC Cancer, 18, Article 744. https://doi.org/10.1186/s12885-018-4662-5
Reynoso-Noverón, N., Mohar-Betancourt, A., & Ortiz-Rafael, J. (2021). Epidemiology of brain tumors. In A. Monroy-Sosa, S. S. Chakravarthi, J. G. de la Garza-Salazar, A. M. Garcia, & A. B. Kassam (Eds.), Principles of neuro-oncology: Brain & skull base (pp. 15–25). Springer. https://doi.org/10.1007/978-3-030-54879-7_2
Sandler, C. X., Matsuyama, M., Jones, T. L., Bashford, J., Langbecker, D., & Hayes, S. C. (2021). Physical activity and exercise in adults diagnosed with primary brain cancer: A systematic review. Journal of Neuro-Oncology, 153(1), 1–14. https://doi.org/10.1007/s11060-021-03745-3
Sandler, C. X., Toohey, K., Jones, T. L., Hayes, S. C., & Spence, R. R. (2020). Supporting those with the most to gain: The potential of exercise in oncology. Seminars in Oncology Nursing, 36(5), Article 151074. https://doi.org/10.1016/j.soncn.2020.151074
Sharma, A., & Graber, J. J. (2021). Overview of prognostic factors in adult gliomas. Annals of Palliative Medicine, 10(1), 863–874. http://dx.doi.org/10.21037/apm-20-640
Sheill, G., Guinan, E., Brady, L., Hevey, D., & Hussey, J. (2019). Exercise interventions for patients with advanced cancer: A systematic review of recruitment, attrition, and exercise adherence rates. Palliative & Supportive Care, 17(6), 686–696. https://doi.org/10.1017/S1478951519000312
Sizoo, E. M., Braam, L., Postma, T. J., Pasman, H. R. W., Heimans, J. J., Klein, M., Reijneveld, J. C., & Taphoorn, M. J. B. (2010). Symptoms and problems in the end-of-life phase of high-grade glioma patients. Neuro-Oncology, 12(11), 1162–1166. https://doi.org/10.1093/neuonc/nop045
Smith, T., Yuan, Y., Walker, E., & Davis, F. (2019, December). Brain Tumour Registry of Canada (BTRC): Incidence report 2010–2015. Brain Tumour Registry of Canada. https://braintumourregistry.ca/incidence-report/
Travers, S., & Litofsky, N. S. (2021). Daily lifestyle modifications to improve quality of life and survival in glioblastoma: A review. Brain Sciences, 11(5), Article 533. https://doi.org/10.3390/brainsci11050533
Walker, E., Zakaria, D., Yuan, Y., Yasmin, F., Shaw, A., & Davis, F. (2021). Brain Tumour Registry of Canada (BTRC): Incidence (2013–2017) and mortality (2014–2018) report. Brain Tumour Registry of Canada. https://braintumourregistry.ca/incidence-and-mortality-report/
Williams, G. R., Dunne, R. F., Giri, S., Shachar, S. S., & Caan, B. J. (2021). Sarcopenia in the older adult with cancer. Journal of Clinical Oncology, 39(19), 2068–2078. https://doi.org/10.1200/JCO.21.00102
Publicado
Edição
Secção
Licença
Direitos de Autor (c) 2024 Jodi Eleanor Langley, Mary MacNeil, Hannah Pace, Hannah Peters, Scott Grandy, Melanie Keats
Este trabalho encontra-se publicado com a Creative Commons Atribuição-NãoComercial 4.0.
The journal aims to reduce barriers to publishing and sharing research and inequalities to accessing information.This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. The open-access nature of the journal means that there will be no charge for authors or readers to use the journal. The journal has a Creative Commons Attribution Non-Commercial (CCBYNC) attribution which allows the author (and others) to share and distribute their full-text article in other public domains, such as Google Scholar or Research Gate.